Bone marrow scintigraphy as a useful method for estimating the physiological status of bone marrow and spleen in polycythaemia vera

Leukemia & Lymphoma
J D RainC Billotey

Abstract

Bone marrow scintigraphy is a simple and noninvasive examination useful to define the status of the bone marrow and spleen in polycythaemia vera (P.V.). Despite the absence of specificity of Indium 111 labelled transferrin (In-Tf) for myelopoietic tissue, there is a close correlation between bone marrow In-Tf uptake and bone marrow cellularity and between splenic In-Tf uptake and splenic metaplasia. The results of scintigraphy are compared to clinical data, radioactive iron kinetics, bone marrow and spleen histology and the course of the disease. The diagnostic and prognostic value of bone marrow scintigraphy is discussed, particularly at the stage of transformation of P.V. into postpolycythaemia myeloid metaplasia (Post-P.V.M.M.).

References

Oct 1, 1978·British Journal of Haematology·Y NajeanC Dresch
Jun 30, 1977·European Journal of Nuclear Medicine·C ParmentierN Morardet
Nov 1, 1990·European Journal of Haematology·Y NajeanJ P Arrago
Jul 1, 1985·Seminars in Nuclear Medicine·F L Datz, A Taylor
Feb 1, 1986·British Journal of Haematology·A FerrantG Sokal
Jan 1, 1984·British Journal of Haematology·Y NajeanC Dresch
Mar 1, 1982·Australian Veterinary Journal·A B Howkins
Nov 1, 1982·Scandinavian Journal of Haematology·A FerrantG Sokal

❮ Previous
Next ❯

Citations

May 10, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·T J Rosol
Apr 22, 2021·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Stefanie SlotSonja Zweegman
Apr 1, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Laetitia VercellinoJean-Jacques Kiladjian

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.